VolgendeVolgende gids
Detectie van tandheelkundige röntgenholten
Visuele AI
Visuele AI-GIDS
AI lung nodule detection uses computer vision models, mostly deep neural networks, to find, measure and assess small spots in the lungs on CT scans, and to estimate how likely each spot is to be cancer.
Luister naar deze gidsAI-verteld · ~3 min
It matters because low-dose CT screening reduces lung cancer deaths. But each scan has hundreds of thin slices to read, and most nodules are harmless. Tools that find nodules reliably and help separate risky ones from harmless ones affect both missed cancers and unnecessary follow-up procedures.
A lung nodule is a rounded spot in the lung up to about 3 cm across. Anything larger is usually called a mass. Nodules are very common, and most are old scars, infections or benign growths. On CT they are described as solid, part-solid or ground-glass, and each type carries a different risk. Screening is where AI has drawn the most attention. The US National Lung Screening Trial, reported in 2011, found that low-dose CT reduced lung cancer deaths by about 20 percent compared with chest X-ray. The European NELSON trial later confirmed a benefit. In 2021 the US Preventive Services Task Force recommended annual screening for adults aged 50 to 80 with at least a 20 pack-year smoking history who still smoke or quit within the past 15 years. The American College of Radiology's Lung-RADS system standardizes how screening scans are reported and followed up. Nodules found by chance on scans done for other reasons are usually managed with Fleischner Society guidelines. AI does three separate jobs. Detection finds candidate nodules. Measurement segments each nodule to get its size and volume. Characterization estimates the risk of cancer. A 2019 Google study in Nature Medicine trained a deep learning model on NLST scans. In retrospective tests without a prior scan to compare, it matched or beat radiologists at predicting cancer. Sybil, developed at MIT and Massachusetts General Hospital, estimates a person's risk of lung cancer over the following years from a single low-dose CT, even when no suspicious nodule is visible. False positives are the central tradeoff. In NLST, roughly a quarter of screens were positive, and the vast majority of those were not cancer. A more sensitive detector marks more spots, which adds reading time, follow-up scans, anxiety and occasionally invasive procedures. A common misconception is that AI diagnoses lung cancer. It flags and estimates risk, and only tissue sampling confirms cancer.
A screening program runs detection software on each low-dose CT. It marks a 5 mm nodule in the right upper lobe sitting next to a blood vessel, where it is easy to miss, and the radiologist confirms it.
Volume-measuring software compares a 7 mm solid nodule with the patient's scan from a year earlier and calculates the change in volume. This helps the radiologist assign a Lung-RADS category and a follow-up interval.
A lung nodule clinic applies a malignancy risk score to a 12 mm nodule that turned up by chance on an emergency CT. The score helps decide between PET-CT, biopsy or repeat imaging.
A health system searches chest CTs that were ordered for other reasons, such as trauma or cardiac scans, and flags incidental nodules that never received a follow-up recommendation.
Researchers are testing how risk models like Sybil might personalize screening intervals, and whether AI can help screening programs expand without adding proportionally to radiologist workload. Screening CTs also show coronary calcium and emphysema, so tools that report those findings may add value. Some programs are exploring screening groups outside the smoking-based criteria, such as people with a family history. The key open questions are how these tools perform prospectively across diverse populations and scanners, and whether they lower the false-positive burden without missing cancers. That evidence is still accumulating.
Gratis nieuwsbrief
Drie verifieerde AI-verhalen elke weekdagmorgen, geschreven in eenvoudig Engels. Gratis voor altijd, geen advertenties.
Eén e-mail elke weekdag. Afmelden met één klik. We verkopen of delen je adres nooit.
Test jezelf
Directe feedback op elke antwoord, en een deelbare certificaat met een verifieerbare ID zodra je een cursus hebt afgerond.
Ondersteun gratis AI-onderwijs. AI Understanding is een 501(c)(3) non-profit — geen advertenties, geen betaalmuur, nooit. Doe een donatie
AI lung nodule detection uses computer vision models, mostly deep neural networks, to find, measure and assess small spots in the lungs on CT scans, and to estimate how likely each spot is to be cancer. It matters because low-dose CT screening reduces lung cancer deaths. But each scan has hundreds of thin slices to read, and most nodules are harmless. Tools that find nodules reliably and help separate risky ones from harmless ones affect both missed cancers and unnecessary follow-up procedures.
NLST vergeleek een lage dosis CT met een röntgenfoto van de thorax en vond met CT een vermindering van het aantal sterfgevallen door longkanker met ongeveer 20 procent.
De aanbeveling voor 2021 heeft betrekking op volwassenen van 50 tot 80 jaar met een voorgeschiedenis van minstens 20 pakjaren die nu roken of in de afgelopen 15 jaar zijn gestopt.
Lung-RADS dekt screeningsexamens. Bij toeval gevonden knobbeltjes op scans die om andere redenen zijn gemaakt, worden meestal behandeld volgens de richtlijnen van de Fleischner Society.
Sybil voorspelt het risico voor de komende jaren op basis van één scan, in plaats van alleen de huidige knobbeltjes te markeren.
FROC-analyse legt de afweging vast tussen het vinden van knobbeltjes en het produceren van valse markeringen op elke scan.
Blijf leren
Er zijn meer handleidingen voor dit onderwerp geselecteerd
VolgendeVolgende gids
Detectie van tandheelkundige röntgenholten
Visuele AI